CDK2 and neoplasm: To further determine if the interferon signaling pathway is involved in MTX-mediated anti-tumor effects in Cdk2-/- tumors, we treated C57 mice carrying Cdk2-/- MCA205 tumors with antibodies that neutralize IFNAR1.